Skip to main content
Erschienen in: Archives of Osteoporosis 1/2017

01.12.2017 | Short Communication

Secondary fracture prevention in hip fracture patients requires cooperation from general practitioners

verfasst von: Jan Vaculík, Jan J. Stepan, Pavel Dungl, Marek Majerníček, Alexander Čelko, Valér Džupa

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Summary

Despite individual recommendations on osteoporosis management in patients after hip fracture surgery, addressed by orthopedic surgeons to Czech general practitioners, the patients remained undiagnosed and untreated because of provider-level barriers to post-fracture secondary prevention.

Purpose

The goal of the study was to assess whether an individual recommendation on osteoporosis treatment addressed to a hip fracture patient’s GP would lead to better osteoporosis management.

Methods

Two groups of patients who suffered hip fractures and were treated at the Orthopedic Department were evaluated. In 111 patients, general recommendations on osteoporosis treatment and fracture prevention were provided in a discharge report addressed to the GP. In the second group, 96 patients were provided individually with a detailed written set of recommendations on osteoporosis examination, treatment, and fracture prevention, which was also provided in the discharge report. A questionnaire to assess the provided care was mailed to the patients 5.3 ± 1.2 months of discharge. Those patients who did not return the questionnaires were contacted by phone.

Results

The questionnaires were received from 44% and 49% of patients from the general and detailed recommendation groups, respectively. Along with the phone call, we were able to contact 78 (70.3%) and 68 (70.8%) patients from the general and detailed recommendation groups, respectively. GPs secured osteoporosis evaluation in 14.6% of the patients. Calcium supplementation and vitamin D supplementation were newly provided in 42.7 and 36.4% of the patients, respectively. Anti-resorptive therapy was newly provided in 8.3% of the patients. No significant differences between the groups were observed in osteoporosis evaluation, calcium and vitamin D supplementation, and anti-osteoporosis treatments. Out of 207 patients, further examination or treatment was requested by 45 patients (21.7%); 75 patients (36.2%) declared no interest in further care.

Conclusion

Recommendations on osteoporosis management addressed to Czech GPs after surgical fracture management had little effect on treatment. As the anti-osteoporotic preparations can only be prescribed by specialists, the availability of necessary examinations and treatment is limited by the motivation of GPs. Consequently, the implementation of Fracture Liaison Services to help close the care gap may be limited in the absence of participation by Czech GPs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Stepan JJ, Vaculik J, Pavelka K, Zofka J, Johansson H, Kanis JA (2012) Hip fracture incidence from 1981 to 2009 in the Czech Republic as a basis of the country-specific FRAX model. Calcif Tissue Int 90:365–372CrossRefPubMed Stepan JJ, Vaculik J, Pavelka K, Zofka J, Johansson H, Kanis JA (2012) Hip fracture incidence from 1981 to 2009 in the Czech Republic as a basis of the country-specific FRAX model. Calcif Tissue Int 90:365–372CrossRefPubMed
2.
Zurück zum Zitat Hernlund E, Svedbom A, Ivergard M, Compston J (2013) A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8 Hernlund E, Svedbom A, Ivergard M, Compston J (2013) A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8
3.
Zurück zum Zitat Edwards BJ, Bunta AD, Simonelli C, Bolander M, Fitzpatrick LA (2007) Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res 461:226–230PubMed Edwards BJ, Bunta AD, Simonelli C, Bolander M, Fitzpatrick LA (2007) Prior fractures are common in patients with subsequent hip fractures. Clin Orthop Relat Res 461:226–230PubMed
4.
Zurück zum Zitat Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387–394CrossRefPubMed Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387–394CrossRefPubMed
5.
Zurück zum Zitat Sobolev B, Sheehan KJ, Kuramoto L, Guy P (2015) Risk of second hip fracture persists for years after initial trauma. Bone 75:72–76CrossRefPubMed Sobolev B, Sheehan KJ, Kuramoto L, Guy P (2015) Risk of second hip fracture persists for years after initial trauma. Bone 75:72–76CrossRefPubMed
6.
Zurück zum Zitat Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res 24:1299–1307CrossRefPubMed Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res 24:1299–1307CrossRefPubMed
7.
Zurück zum Zitat Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809CrossRefPubMed Lyles KW, Colon-Emeric CS, Magaziner JS et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809CrossRefPubMed
8.
Zurück zum Zitat Osaki M, Tatsuki K, Hashikawa T, Norimatsu T, Chiba K, Motokawa S, Furuichi I, Doiguchi Y, Aoyagi K, Shindo H (2012) Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women. Osteoporos Int 23:695–703CrossRefPubMed Osaki M, Tatsuki K, Hashikawa T, Norimatsu T, Chiba K, Motokawa S, Furuichi I, Doiguchi Y, Aoyagi K, Shindo H (2012) Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women. Osteoporos Int 23:695–703CrossRefPubMed
9.
Zurück zum Zitat Boonen S, Adachi JD, Man Z et al (2011) Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocrinol Metab 96:1727–1736CrossRefPubMed Boonen S, Adachi JD, Man Z et al (2011) Treatment with denosumab reduces the incidence of new vertebral and hip fractures in postmenopausal women at high risk. J Clin Endocrinol Metab 96:1727–1736CrossRefPubMed
10.
Zurück zum Zitat Kanis JA, Svedbom A, Harvey N, McCloskey EV (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926–1928CrossRefPubMed Kanis JA, Svedbom A, Harvey N, McCloskey EV (2014) The osteoporosis treatment gap. J Bone Miner Res 29:1926–1928CrossRefPubMed
11.
Zurück zum Zitat Gillespie CW, Morin PE (2017) Osteoporosis-related health services utilization following first hip fracture among a cohort of privately-insured women in the United States, 2008–2014: an observational study. J Bone Miner Res Gillespie CW, Morin PE (2017) Osteoporosis-related health services utilization following first hip fracture among a cohort of privately-insured women in the United States, 2008–2014: an observational study. J Bone Miner Res
12.
Zurück zum Zitat Sale JE, Gignac MA, Frankel L, Hawker G, Beaton D, Elliot-Gibson V, Bogoch E (2012) Patients reject the concept of fragility fracture-a new understanding based on fracture patients' communication. Osteoporos Int 23:2829–2834CrossRefPubMed Sale JE, Gignac MA, Frankel L, Hawker G, Beaton D, Elliot-Gibson V, Bogoch E (2012) Patients reject the concept of fragility fracture-a new understanding based on fracture patients' communication. Osteoporos Int 23:2829–2834CrossRefPubMed
13.
Zurück zum Zitat Beaton DE, Dyer S, Jiang D, Sujic R, Slater M, Sale JE, Bogoch ER, Osteoporosis Fracture Clinic Screening Program Evaluation T (2014) Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario osteoporosis strategy’s fracture clinic screening program. Osteoporos Int 25:289–296CrossRefPubMed Beaton DE, Dyer S, Jiang D, Sujic R, Slater M, Sale JE, Bogoch ER, Osteoporosis Fracture Clinic Screening Program Evaluation T (2014) Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario osteoporosis strategy’s fracture clinic screening program. Osteoporos Int 25:289–296CrossRefPubMed
14.
Zurück zum Zitat Stepan J, Vaculík J, Palička V, Dungl P, Vyskočil V, Pavelka K (2015) Péče o pacienty s nízkotraumatickou zlomeninou horního konce stehenní kosti. II. Následná osteologická péče. Čes Revmatologie 23:43–56 Stepan J, Vaculík J, Palička V, Dungl P, Vyskočil V, Pavelka K (2015) Péče o pacienty s nízkotraumatickou zlomeninou horního konce stehenní kosti. II. Následná osteologická péče. Čes Revmatologie 23:43–56
15.
Zurück zum Zitat Palicka V, Blahos J, Byma S (2011) Osteoporóza. Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře. Novelizace 2011. Společnost všeobecného lékařství ČLS JEP, Centrun doporučených postupů pro praktické lékaře, Prague Palicka V, Blahos J, Byma S (2011) Osteoporóza. Doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře. Novelizace 2011. Společnost všeobecného lékařství ČLS JEP, Centrun doporučených postupů pro praktické lékaře, Prague
16.
Zurück zum Zitat Blazkova S, Vytrisalova M, Palicka V, Stepan J, Byma S, Kubena AA, Hala T, Vlcek J (2010) Osteoporosis risk assessment and management in primary care: focus on quantity and quality. J Eval Clin Pract 16:1176–1182CrossRefPubMed Blazkova S, Vytrisalova M, Palicka V, Stepan J, Byma S, Kubena AA, Hala T, Vlcek J (2010) Osteoporosis risk assessment and management in primary care: focus on quantity and quality. J Eval Clin Pract 16:1176–1182CrossRefPubMed
17.
Zurück zum Zitat Chenot R, Scheidt-Nave C, Gabler S, Kochen MM, Himmel W (2007) German primary care doctors’ awareness of osteoporosis and knowledge of national guidelines. Exp Clin Endocrinol Diabetes 115:584–589CrossRefPubMed Chenot R, Scheidt-Nave C, Gabler S, Kochen MM, Himmel W (2007) German primary care doctors’ awareness of osteoporosis and knowledge of national guidelines. Exp Clin Endocrinol Diabetes 115:584–589CrossRefPubMed
18.
Zurück zum Zitat Port L, Center J, Briffa NK, Nguyen T, Cumming R, Eisman J (2003) Osteoporotic fracture: missed opportunity for intervention. Osteoporos Int 14:780–784CrossRefPubMed Port L, Center J, Briffa NK, Nguyen T, Cumming R, Eisman J (2003) Osteoporotic fracture: missed opportunity for intervention. Osteoporos Int 14:780–784CrossRefPubMed
19.
Zurück zum Zitat Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C, Group IOFFW (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152CrossRefPubMedPubMedCentral Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, Kyer C, Cooper C, Group IOFFW (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Merle B, Chapurlat R, Vignot E, Thomas T, Haesebaert J, Schott AM (2017) Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial. Osteoporos Int Merle B, Chapurlat R, Vignot E, Thomas T, Haesebaert J, Schott AM (2017) Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial. Osteoporos Int
21.
Zurück zum Zitat Hoang-Kim A, Schemitsch E, Sale JE, Beaton D, Warmington K, Kulkarni AV, Reeves S (2014) Understanding osteoporosis and fractures: an introduction to the use of qualitative research. Arch Orthop Trauma Surg 134:207–217CrossRefPubMed Hoang-Kim A, Schemitsch E, Sale JE, Beaton D, Warmington K, Kulkarni AV, Reeves S (2014) Understanding osteoporosis and fractures: an introduction to the use of qualitative research. Arch Orthop Trauma Surg 134:207–217CrossRefPubMed
22.
Zurück zum Zitat Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA (2002) Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 47:651–654CrossRefPubMed Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA (2002) Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 47:651–654CrossRefPubMed
23.
Zurück zum Zitat Mosk CA, Mus M, Jos PAM, Vroemen JPAM, van der Ploeg T, Vos DI, Elmans LHGJ, van der Laan L (2017) Dementia and delirium, the outcomes in elderly hip fracture patients. Clin Interv Aging 12:421–430CrossRefPubMedPubMedCentral Mosk CA, Mus M, Jos PAM, Vroemen JPAM, van der Ploeg T, Vos DI, Elmans LHGJ, van der Laan L (2017) Dementia and delirium, the outcomes in elderly hip fracture patients. Clin Interv Aging 12:421–430CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Prieto-Alhambra D, Judge A, Arden NK, Cooper C, Lyles KW, Javaid MK (2014) Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON recurrent fracture trial. Osteoporos Int 25:77–83CrossRefPubMed Prieto-Alhambra D, Judge A, Arden NK, Cooper C, Lyles KW, Javaid MK (2014) Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON recurrent fracture trial. Osteoporos Int 25:77–83CrossRefPubMed
25.
Zurück zum Zitat Jin J, Sklar GE, Min Sen Oh V, Chuen Li S (2008) Factors affecting therapeutic compliance: a review from the patient's perspective. Ther Clin Risk Manag 4:269–286CrossRefPubMedPubMedCentral Jin J, Sklar GE, Min Sen Oh V, Chuen Li S (2008) Factors affecting therapeutic compliance: a review from the patient's perspective. Ther Clin Risk Manag 4:269–286CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Sale JE, Bogoch E, Hawker G, Gignac M, Beaton D, Jaglal S, Frankel L (2014) Patient perceptions of provider barriers to post-fracture secondary prevention. Osteoporos Int 25:2581–2589CrossRefPubMed Sale JE, Bogoch E, Hawker G, Gignac M, Beaton D, Jaglal S, Frankel L (2014) Patient perceptions of provider barriers to post-fracture secondary prevention. Osteoporos Int 25:2581–2589CrossRefPubMed
Metadaten
Titel
Secondary fracture prevention in hip fracture patients requires cooperation from general practitioners
verfasst von
Jan Vaculík
Jan J. Stepan
Pavel Dungl
Marek Majerníček
Alexander Čelko
Valér Džupa
Publikationsdatum
01.12.2017
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2017
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-017-0346-z

Weitere Artikel der Ausgabe 1/2017

Archives of Osteoporosis 1/2017 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.